Network Model Integrated with Multi-omic Data Predicts MBNL1 Signals That Drive Myofibroblast Activation

Overview

Journal iScience

Publisher Cell Press

Date 2023 Apr 24

PMID 37091233

Authors

Anders R Nelson

Darrian Bugg

Jennifer Davis

Jeffrey J Saucerman

Affiliations

Soon will be listed here.

Abstract

RNA-binding protein muscleblind-like1 (MBNL1) was recently identified as a central regulator of cardiac wound healing and myofibroblast activation. To identify putative MBNL1 targets, we integrated multiple genome-wide screens with a fibroblast network model. We expanded the model to include putative MBNL1-target interactions and recapitulated published experimental results to validate new signaling modules. We prioritized 14 MBNL1 targets and developed novel fibroblast signaling modules for p38 MAPK, Hippo, Runx1, and Sox9 pathways. We experimentally validated MBNL1 regulation of p38 expression in mouse cardiac fibroblasts. Using the expanded fibroblast model, we predicted a hierarchy of MBNL1 regulated pathways with strong influence on αSMA expression. This study lays a foundation to explore the network mechanisms of MBNL1 signaling central to fibrosis.

Citing Articles

Functions of the Muscleblind-like protein family and their role in disease.

Zhou H, Xu J, Pan L Cell Commun Signal. 2025; 23(1):97.

PMID: 39966885 PMC: 11837677. DOI: 10.1186/s12964-025-02102-5.

Multiscale computational model predicts how environmental changes and treatments affect microvascular remodeling in fibrotic disease.

Leonard-Duke J, Agro S, Csordas D, Bruce A, Eggertsen T, Tavakol T PNAS Nexus. 2024; 4(1):pgae551.

PMID: 39720203 PMC: 11667245. DOI: 10.1093/pnasnexus/pgae551.

Multiscale computational model predicts how environmental changes and drug treatments affect microvascular remodeling in fibrotic disease.

Leonard-Duke J, Agro S, Csordas D, Bruce A, Eggertsen T, Tavakol T bioRxiv. 2024; .

PMID: 38559112 PMC: 10979947. DOI: 10.1101/2024.03.15.585249.

Cavin-2 promotes fibroblast-to-myofibroblast trans-differentiation and aggravates cardiac fibrosis.

Higuchi Y, Ogata T, Nakanishi N, Nishi M, Tsuji Y, Tomita S ESC Heart Fail. 2023; 11(1):167-178.

PMID: 37872863 PMC: 10804157. DOI: 10.1002/ehf2.14571.

References

Herum K, Choppe J, Kumar A, Engler A, McCulloch A . Mechanical regulation of cardiac fibroblast profibrotic phenotypes. Mol Biol Cell. 2017; 28(14):1871-1882. PMC: 5541838. DOI: 10.1091/mbc.E17-01-0014. View

Francis Stuart S, De Jesus N, Lindsey M, Ripplinger C . The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. J Mol Cell Cardiol. 2016; 91:114-22. PMC: 4764395. DOI: 10.1016/j.yjmcc.2015.12.024. View

Zeigler A, Nelson A, Chandrabhatla A, Brazhkina O, Holmes J, Saucerman J . Computational model predicts paracrine and intracellular drivers of fibroblast phenotype after myocardial infarction. Matrix Biol. 2020; 91-92:136-151. PMC: 7434705. DOI: 10.1016/j.matbio.2020.03.007. View

Parichatikanond W, Luangmonkong T, Mangmool S, Kurose H . Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling. Front Cardiovasc Med. 2020; 7:34. PMC: 7075814. DOI: 10.3389/fcvm.2020.00034. View

Zhao S, Kurenbekova L, Gao Y, Roos A, Creighton C, Rao P . NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma. Oncogene. 2015; 34(39):5069-79. PMC: 4802362. DOI: 10.1038/onc.2014.429. View

Lacraz G, Junker J, Gladka M, Molenaar B, Scholman K, Vigil-Garcia M . Tomo-Seq Identifies SOX9 as a Key Regulator of Cardiac Fibrosis During Ischemic Injury. Circulation. 2017; 136(15):1396-1409. DOI: 10.1161/CIRCULATIONAHA.117.027832. View

Pang X, Lin X, Du J, Zeng D . LTBP2 knockdown by siRNA reverses myocardial oxidative stress injury, fibrosis and remodelling during dilated cardiomyopathy. Acta Physiol (Oxf). 2019; 228(3):e13377. DOI: 10.1111/apha.13377. View

Islam M, Itoh S, Yanagita T, Sumiyoshi K, Hayano S, Kuremoto K . Runx/Cbfb signaling regulates postnatal development of granular convoluted tubule in the mouse submandibular gland. Dev Dyn. 2014; 244(3):488-96. DOI: 10.1002/dvdy.24231. View

Zeigler A, Richardson W, Holmes J, Saucerman J . A computational model of cardiac fibroblast signaling predicts context-dependent drivers of myofibroblast differentiation. J Mol Cell Cardiol. 2016; 94:72-81. PMC: 4861657. DOI: 10.1016/j.yjmcc.2016.03.008. View

10.

Gorelik M, Lee Y, Abe M, Andrews T, Davis L, Patterson J . IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis. Clin Exp Immunol. 2019; 198(1):101-110. PMC: 6718290. DOI: 10.1111/cei.13314. View

11.

Travers J, Tharp C, Rubino M, McKinsey T . Therapeutic targets for cardiac fibrosis: from old school to next-gen. J Clin Invest. 2022; 132(5). PMC: 8884906. DOI: 10.1172/JCI148554. View

12.

Canzler S, Schor J, Busch W, Schubert K, Rolle-Kampczyk U, Seitz H . Prospects and challenges of multi-omics data integration in toxicology. Arch Toxicol. 2020; 94(2):371-388. DOI: 10.1007/s00204-020-02656-y. View

13.

Chothani S, Schafer S, Adami E, Viswanathan S, Widjaja A, Langley S . Widespread Translational Control of Fibrosis in the Human Heart by RNA-Binding Proteins. Circulation. 2019; 140(11):937-951. PMC: 6749977. DOI: 10.1161/CIRCULATIONAHA.119.039596. View

14.

Li M, Wu J, Hu G, Song Y, Shen J, Xin J . Pathological matrix stiffness promotes cardiac fibroblast differentiation through the POU2F1 signaling pathway. Sci China Life Sci. 2020; 64(2):242-254. DOI: 10.1007/s11427-019-1747-y. View

15.

Bujak M, Frangogiannis N . The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2006; 74(2):184-95. PMC: 1924687. DOI: 10.1016/j.cardiores.2006.10.002. View

16.

Landry N, Rattan S, Dixon I . An Improved Method of Maintaining Primary Murine Cardiac Fibroblasts in Two-Dimensional Cell Culture. Sci Rep. 2019; 9(1):12889. PMC: 6733858. DOI: 10.1038/s41598-019-49285-9. View

17.

Yasuda H, Oh C, Chen D, de Crombrugghe B, Kim J . A Novel Regulatory Mechanism of Type II Collagen Expression via a SOX9-dependent Enhancer in Intron 6. J Biol Chem. 2016; 292(2):528-538. PMC: 5241729. DOI: 10.1074/jbc.M116.758425. View

18.

Trembley M, Quijada P, Agullo-Pascual E, Tylock K, Colpan M, Dirkx Jr R . Mechanosensitive Gene Regulation by Myocardin-Related Transcription Factors Is Required for Cardiomyocyte Integrity in Load-Induced Ventricular Hypertrophy. Circulation. 2018; 138(17):1864-1878. PMC: 6202206. DOI: 10.1161/CIRCULATIONAHA.117.031788. View

19.

Velasquez L, Sutherland L, Liu Z, Grinnell F, Kamm K, Schneider J . Activation of MRTF-A-dependent gene expression with a small molecule promotes myofibroblast differentiation and wound healing. Proc Natl Acad Sci U S A. 2013; 110(42):16850-5. PMC: 3801009. DOI: 10.1073/pnas.1316764110. View

20.

Cui S, Liu Z, Tao B, Fan S, Pu Y, Meng X . miR-145 attenuates cardiac fibrosis through the AKT/GSK-3β/β-catenin signaling pathway by directly targeting SOX9 in fibroblasts. J Cell Biochem. 2020; 122(2):209-221. DOI: 10.1002/jcb.29843. View